Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Vinchurkar, W. Vos, C. Holsbeke, J. De Backer, G. Poli, W. De Backer (Kontich, Edegem, Belgium; Parma, Italy). The effects of extrafine beclomethasone/formoterol on hyperinflation and airway geometry in COPD patients. Eur Respir J 2012; 40: Suppl. 56, 4833

Member's Comments

No comment yet.

Related content which might interest you: Maintenance of lung function and asthma control with extrafine beclomethasone/formoterol Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Reliever effect of extrafine BDP/F DPI in asthmatic patients after methacholine challenge Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Effects of tiotropium and salmeterol/fluticasone combination on lung hyperinflation, dyspnea and exercise tolerance in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006 Additional benefits of beclomethasone/formoterol extrafine combination treatment on small airways function in asthma Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009 Reduction in air trapping and dyspnea with an extrafine combination of beclomethasone and formoterol in COPD Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010 Beclomethasone, formoterol and glycopyrronium: ceiling effect in small airways of COPD patients Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020 Effect of indacaterol maleate on dynamic lung hyperinflation in patients with COPD Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009 Nebulized formoterol improves airway function in COPD subjects receiving maintenance tiotropium Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Dissociation in effects of fluticasone but not fluticasone/salmeterol on lung function and airway hyperresponsiveness in mild persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 385s Year: 2002 Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD Source: Eur Respir J 2003; 21: 86-94 Year: 2003 Differentiation of bronchodilator effects of indacaterol and formoterol by FEV1 and inspiratory capacity (IC) in patients with COPD Source: Annual Congress 2007 - New drugs for COPD Year: 2007 Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients Source: Annual Congress 2010 - COPD: management Year: 2010 COPD exacerbations are reduced by budesonide/formoterol in a single inhaler Source: Eur Respir J 2003; 22: Suppl. 45, 238s Year: 2003 Efficacy of combined budesonide/formoterol delivered via turbuhaler on lung function and asthma control in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 496s Year: 2003 Efficacy of tiotropium and indacaterol alone or the combination on dynamic lung hyperinflation and exercise tolerance in COPD Source: International Congress 2014 – Asthma and COPD management Year: 2014 Effects of budesonide/formoterol combination therapy versus budesonide on airway dimensions in asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Evaluation of the acute bronchodilator effect of beclomethasone/formoterol fixed combination on central and peripheral airway dimensions in asthmatic patients Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Efficacy of the device in targeting tiotropium to the small airways in COPD Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 The effect of tiotropium in COPD complicated with asthma Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007